ANDROGEN AND PROGESTERONE METABOLISM IN THE CENTRAL AND PERIPHERAL NERVOUS-SYSTEM

被引:81
|
作者
MARTINI, L
MELCANGI, RC
MAGGI, R
机构
[1] Isituto di Endocrinologia, Università degli Studi di Milano, Milano
关键词
D O I
10.1016/0960-0760(93)90075-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This paper summarizes the most recent data obtained in the authors' laboratory on the metabolism of testosterone and progesterone in neurons, in the glia, and in neuroblastoma cells. The activities of the 5 alpha-reductase (the enzyme that converts testosterone into dihydrotestosterone, DHT), and of the 3 alpha-hydroxysteroid dehydrogenase (the enzyme that converts DHT into 5 alpha-androstane-3 alpha, 17 beta-diol, 3 alpha-diol) have been first evaluated in primary cultures of neurons, oligodendrocytes and type-1 and -2 astrocytes, obtained from the fetal or neonatal rat brain. All the cultures were used on the fifth day. The formation of DHT or 3 alpha-diol was evaluated incubating the different cultures with labeled testosterone or DHT as substrates. The results obtained indicate that the formation of DHT takes place preferentially in neurons; however, type-2 astrocytes and oligodendrocytes also possess considerable 5 alpha-reductase activity, while type-1 astrocytes show a much lower enzymatic concentration. A completely different localization was observed for 3 alpha-hydroxysteroid dehydrogenase; the formation of 3 alpha-diol appears to be prevalently, if not exclusively, present in type-1 astrocytes; 3 alpha-diol is formed in very low yields by neurons, type-2 astrocytes and oligodendrocytes. The compartmentalization of two strictly correlated enzymes (5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase) in separate central nervous system (CNS) cell populations suggests the simultaneous participation of neurons and glial cells in the 5 alpha-reductive metabolism of testosterone. Subsequently it has been shown that, similarly to what happens when testosterone is used as the substrate, the 5 alpha-reductase which metabolizes progesterone into 5 alpha-pregnane-3,20-dione (DHP) shows a significantly higher activity in neurons than in glial cells; however, type-1 and -2 astrocytes as well as oligodendrocytes also possess some ability to 5 alpha-reduce progesterone. On the other hand, 3 alpha-hydroxysteroid dehydrogenase, the enzyme which converts DHP into 5 alpha-pregnane-3 alpha-ol-20-one, appears to be present mainly in type-1 astrocytes; much lower levels of this enzyme are present in neurons and in type-2 astrocytes. At variance with the previous results obtained using androgens as precursors, oligodendrocytes show considerable 3 alpha-hydroxysteroid dehydrogenase activity, even if this is statistically lower than that present in type-1 astrocytes. The existence of isoforms of the enzyme involved in androgen and progesterone metabolism is discussed. Finally, the ability of the human neuroblastoma cell line SH-SY5Y to metabolize androgens and progesterone was studied incubating the cells in the presence of labeled testosterone or progesterone to measure, respectively, the formation of DHT or DHP (5 alpha-reductase activity). 3 alpha-Hydroxysteroid dehydrogenase activity was studied by evaluating the conversion of labeled DHT into 3 alpha-diol. The results demonstrate that undifferentiated neuroblastoma cells possess a significant 5 alpha-reductase activity, as shown by the considerable conversion of testosterone into DHT; moreover, this enzymatic activity seems to be significantly stimulated following cell differentiation induced by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), but not after differentiation induced by retinoic acid (RA). The 5 alpha-reductase present in SH-SY5Y cells is also able to convert progesterone into DHP. In undifferentiated cells, this conversion is about 8 times higher than that of testosterone into DHT. Under the influences of TPA and RA, the formation of DHP follows the same pattern observed for that of DHT. SH-SY5Y cells also appear to possess the enzyme 3 alpha-hydroxysteroid dehydrogenase, since they are able to convert DHT into 3 alpha-diol. This enzymatic activity is not altered following TPA-induced differentiation, and appears to be decreased following treatment with RA. It is suggested that the SH-SY5Y cell line may represent a useful ''in vitro'' model for the study of the mechanisms involved in the control of androgen and progesterone metabolism in nervous cells.
引用
收藏
页码:195 / 205
页数:11
相关论文
共 50 条
  • [1] EFFECT OF PERIPHERAL ETHANOL-METABOLISM ON CENTRAL NERVOUS-SYSTEM
    MAJCHROWICZ, E
    [J]. FEDERATION PROCEEDINGS, 1975, 34 (10) : 1948 - 1952
  • [2] PERSISTENT INFECTIONS - CENTRAL NERVOUS-SYSTEM AND PERIPHERAL NERVOUS-SYSTEM
    RODGERSJOHNSON, PEB
    [J]. ARCHIVES OF NEUROLOGY, 1988, 45 (11) : 1281 - 1281
  • [3] SARCOIDOSIS OF THE CENTRAL AND PERIPHERAL NERVOUS-SYSTEM
    CESARO, P
    DEFER, G
    BARBIZET, J
    DEGOS, JD
    [J]. ANNALES DE MEDECINE INTERNE, 1984, 135 (02): : 144 - 148
  • [4] CENTRAL AND PERIPHERAL NERVOUS-SYSTEM ABNORMALITIES
    BREW, BJ
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1992, 76 (01) : 63 - 81
  • [5] SARCOIDOSIS OF THE CENTRAL AND PERIPHERAL NERVOUS-SYSTEM
    CESARO, P
    DEFER, G
    BARBIZET, J
    DEGOS, JD
    [J]. ANNALES DE MEDECINE INTERNE, 1983, 134 (03): : 273 - 273
  • [6] CENTRAL AND PERIPHERAL NERVOUS-SYSTEM COMPLICATIONS
    BROWN, MR
    DYCK, PJ
    MCCLEARN, GE
    SIMA, AAF
    POWELL, HC
    PORTE, D
    [J]. DIABETES, 1982, 31 : 65 - 70
  • [7] AGING OF THE CENTRAL AND PERIPHERAL NERVOUS-SYSTEM
    BALDYMOULINIER, M
    [J]. ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1981, 52 (02): : P27 - P27
  • [8] METABOLISM OF PUTRESCINE IN CENTRAL NERVOUS-SYSTEM
    KONISHI, H
    NAKAJIMA, T
    SANO, I
    [J]. JOURNAL OF BIOCHEMISTRY, 1977, 81 (02): : 355 - 360
  • [9] THE POLYAMINES AND THEIR METABOLISM IN THE CENTRAL NERVOUS-SYSTEM
    SEILER, N
    [J]. ITALIAN JOURNAL OF BIOCHEMISTRY, 1985, 34 (03): : A153 - A155
  • [10] GLYCINE METABOLISM IN CENTRAL NERVOUS-SYSTEM
    UHR, ML
    SNEDDON, MK
    [J]. PROCEEDINGS OF THE AUSTRALIAN BIOCHEMICAL SOCIETY, 1972, 5 (NMAY): : 17 - &